Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Depreciation and Depletion: 2017-2023

Historic Depreciation and Depletion for Bicycle Therapeutics (BCYC) over the last 7 years, with Dec 2023 value amounting to $6.5 million.

  • Bicycle Therapeutics' Depreciation and Depletion changed negligibly% to $1.6 million in Q2 2024 from the same period last year, while for Jun 2024 it was $6.6 million, marking a year-over-year increase of 10.00%. This contributed to the annual value of $6.5 million for FY2023, which is 75.68% up from last year.
  • According to the latest figures from FY2023, Bicycle Therapeutics' Depreciation and Depletion is $6.5 million, which was up 75.68% from $3.7 million recorded in FY2022.
  • In the past 5 years, Bicycle Therapeutics' Depreciation and Depletion registered a high of $6.5 million during FY2023, and its lowest value of $1.0 million during FY2019.
  • In the last 3 years, Bicycle Therapeutics' Depreciation and Depletion had a median value of $3.7 million in 2022 and averaged $3.9 million.
  • Data for Bicycle Therapeutics' Depreciation and Depletion shows a peak YoY skyrocketed of 164.29% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Depreciation and Depletion stood at $1.0 million in 2019, then soared by 30.00% to $1.3 million in 2020, then increased by 7.69% to $1.4 million in 2021, then skyrocketed by 164.29% to $3.7 million in 2022, then soared by 75.68% to $6.5 million in 2023.